Clinical & Translational Oncology · 2021 · 103 citations · 32 references
MedicineOncologySurgeryChemotherapyOral OncologySurgical OncologyImmunotherapy For Oral CancerOral Cancer MetastasisOral Cavity CancerOropharyngeal CancerOropharyngeal SurgerySquamous Cell CarcinomaHistopathology Of Oropharyngeal CancerHuman Papillomavirus-associated Oropharyngeal Cancer SurgeryImmune Checkpoint ReceptorsImmune Checkpoint ResistanceMedical Oncology IntegrationRecurrent Metastatic DiseaseSentinel Lymph Node Biopsy GuidanceSquamous Cell Carcinoma Histology
Abstract Head and neck cancers (HNC) are defined as malignant tumours located in the upper aerodigestive tract and represents 5% of oncologic cases in adults in Spain. More than 90% of these tumours have squamous histology. In an effort to incorporate evidence obtained since 2017 publication, the Spanish Society of Medical Oncology (SEOM) presents an update of the squamous cell HNC diagnosis and treatment guideline. Most relevant diagnostic and therapeutic changes from the last guideline have been updated: introduction of sentinel node biopsy in early oral/oropharyngeal cancer treated with surgery, concomitant radiotherapy with weekly cisplatin 40 mg/m 2 in the adjuvant setting, new approaches for HPV-related oropharyngeal cancer and new treatments with immune-checkpoint inhibitors in recurrent/metastatic disease.
32
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang, Jonathan Harris, Richard Wheeler et al. · New England Journal of Medicine · 2010 · 6.5K citations · Full text
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
Robert L. Ferris, George R. Blumenschein, Jérôme Fayette et al. · New England Journal of Medicine · 2016 · 5.1K citations · Full text
Medicine, Oncology, Metastasis +5
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
Jan B. Vermorken, Fernando Rivera, Éva Remenár et al. · New England Journal of Medicine · 2008 · 3.7K citations · Full text
Medicine, Oncology, Pharmacology +16